Immune response to specific molecules of the retina in proliferative vitreoretinal disorders.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 8045440)

Published in Graefes Arch Clin Exp Ophthalmol on May 01, 1994

Authors

S Grisanti1, K Heimann, P Wiedemann

Author Affiliations

1: Department of Vitreoretinal Surgery, Universitäts-Augenklinik Köln, Cologne, Germany.

Articles by these authors

A standardized classification of ocular trauma. Ophthalmology (1996) 4.05

Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost (2010) 2.02

A standardized classification of ocular trauma. Graefes Arch Clin Exp Ophthalmol (1996) 1.60

Prophylactically-administered rectal acetaminophen does not reduce postoperative opioid requirements in infants and small children undergoing elective cleft palate repair. Anesth Analg (2001) 1.56

Current understanding on the role of retinal pigment epithelium and its pigmentation. Pigment Cell Res (1999) 1.51

Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina (2000) 1.46

Transplantation of autologous iris pigment epithelium to the subretinal space in rabbits. Transplantation (1999) 1.45

Refractive lens exchange combined with pars plana vitrectomy to correct high myopia. Eye (Lond) (2005) 1.44

[Progress in somatic gene therapy of retinal degeneration in the animal model]. Ophthalmologe (2002) 1.40

[Management of submacular hemorrhage by tissue plasminogen activator and SF(6) gas injection]. Ophthalmologe (1999) 1.37

Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol (1998) 1.27

Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations. Br J Ophthalmol (1993) 1.24

Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation. Br J Ophthalmol (2000) 1.23

Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy. Br J Ophthalmol (2001) 1.18

Massive suprachoroidal hemorrhage: secondary treatment and outcome. Graefes Arch Clin Exp Ophthalmol (2000) 1.17

P2X7 receptors in Müller glial cells from the human retina. J Neurosci (2000) 1.16

Influence of membrane differential filtration on the natural course of age-related macular degeneration: a randomized trial. Retina (2000) 1.15

Primary vitrectomy for pseudophakic retinal detachment. Br J Ophthalmol (1996) 1.10

Substratum adhesion and gliding in a diatom are mediated by extracellular proteoglycans. Planta (1997) 1.09

PINCO: personal information and confidentiality controls. Long Range Plann (1983) 1.09

Retinal detachment in eyes with congenital glaucoma. Retina (1992) 1.08

Histopathological findings in eyes after silicone oil injection. Graefes Arch Clin Exp Ophthalmol (1986) 1.07

Melanin granules of retinal pigment epithelium are connected with the lysosomal degradation pathway. Exp Eye Res (1999) 1.05

Successful long-term implantation of electrically inactive epiretinal microelectrode arrays in rabbits. Retina (1999) 1.04

The mouse homolog of the Wiskott-Aldrich syndrome protein (WASP) gene is highly conserved and maps near the scurfy (sf) mutation on the X chromosome. Genomics (1995) 1.03

Vesicle budding on Golgi membranes: regulation by G proteins and myosin motors. Biochim Biophys Acta (1998) 1.02

Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease. Br J Ophthalmol (1995) 1.02

Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place? Int Ophthalmol (1990) 1.01

Hysterical symptoms in ophthalmology. Doc Ophthalmol (1989) 1.01

The mRNA expression of cytokines and their receptors in cultured iris pigment epithelial cells: a comparison with retinal pigment epithelial cells. Exp Eye Res (1998) 1.00

[Hyperbaric oxygen therapy in retinal artery occlusion]. Ophthalmologe (2000) 1.00

The GRIP domain is a specific targeting sequence for a population of trans-Golgi network derived tubulo-vesicular carriers. Traffic (2001) 0.99

Evoked cortical potentials after electrical stimulation of the inner retina in rabbits. Graefes Arch Clin Exp Ophthalmol (2000) 0.98

Validity of two-dimensional data obtained with the Heidelberg Retina Tomograph as verified by direct measurements in normal optic nerve heads. Ger J Ophthalmol (1994) 0.98

Immunochemical studies of epiretinal membranes using APAAP complexes: evidence for macrophage involvement in traumatic proliferative vitreoretinopathy. Int Ophthalmol (1988) 0.98

Autologous platelet treatment for optic disc pit associated with persistent macular detachment. Graefes Arch Clin Exp Ophthalmol (1998) 0.98

Elevated vitreous nitric oxide levels in patients with proliferative diabetic retinopathy. Am J Ophthalmol (2000) 0.95

[Late complications following silicone injection. Long-term follow-up of 100 cases]. Klin Monbl Augenheilkd (1986) 0.95

Electrophysiology of rabbit Müller (glial) cells in experimental retinal detachment and PVR. Invest Ophthalmol Vis Sci (2001) 0.94

GAIP, a Galphai-3-binding protein, is associated with Golgi-derived vesicles and protein trafficking. Am J Physiol (1999) 0.94

Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis. Exp Eye Res (1997) 0.94

VEGF release by retinal glia depends on both oxygen and glucose supply. Neuroreport (2000) 0.93

Experimental retinal detachment causes widespread and multilayered degeneration in rabbit retina. J Neurocytol (2001) 0.93

Retinal microglia: a new cell in idiopathic proliferative vitreoretinopathy? Exp Eye Res (1991) 0.92

Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy. Am J Ophthalmol (1987) 0.92

Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Effective doses in vitro and in vivo. Invest Ophthalmol Vis Sci (1985) 0.92

[Scleral buckling operations in rhegmatous retinal detachment]. Ophthalmologe (2002) 0.92

The artificial iris diaphragm for vitreoretinal silicone oil surgery. Retina (1997) 0.91

Temporary vitreous gas tamponade by perfluoromethylcyclopentane. Graefes Arch Clin Exp Ophthalmol (1998) 0.89

Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit. Graefes Arch Clin Exp Ophthalmol (1984) 0.89

Cloning and functional characterization of the human norepinephrine transporter gene promoter. J Neural Transm (Vienna) (1998) 0.89

Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro. Graefes Arch Clin Exp Ophthalmol (2002) 0.89

Control of experimental massive periretinal proliferation by daunomycin: dose-response relation. Graefes Arch Clin Exp Ophthalmol (1983) 0.88

Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages. Graefes Arch Clin Exp Ophthalmol (1993) 0.88

Proliferative retinal diseases: myofibroblasts cause chronic vitreoretinal traction. Br J Ophthalmol (1992) 0.88

Improved photoinactivation of gram-negative and gram-positive methicillin-resistant bacterial strains using a new near-infrared absorbing meso-tetrahydroporphyrin: a comparative study with a chlorine e6 photosensitizer photolon. Methods Find Exp Clin Pharmacol (2008) 0.88

[Early vitrectomy with primary silicone oil injection in very severely injured eyes]. Klin Monbl Augenheilkd (1988) 0.88

[External ophthalmic myiasis cause by Oestrus ovis (sheep and goat botfly)]. Klin Monbl Augenheilkd (1996) 0.87

Pars plana vitrectomy, endolaser coagulation of the retina and the ciliary body combined with silicone oil endotamponade in the treatment of uncontrolled neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol (1999) 0.87

Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders. Ger J Ophthalmol (1995) 0.87

[Contribution on the clinical aspects of the Goldenhar syndrome]. Klin Monbl Augenheilkd (1968) 0.87

The pathophysiology of proliferative vitreoretinopathy. Acta Ophthalmol Suppl (1988) 0.86

Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol (1991) 0.86

[Effects of fluorescein and indocyanine green angiography on subsequent dark adaptation and the electroretinogram]. Klin Monbl Augenheilkd (1996) 0.86

360 degrees retinectomy in severe anterior PVR and PDR. Int Ophthalmol (1999) 0.86

Oculocerebral non-Hodgkin's lymphoma with uveal involvement: development of an epibulbar tumor after vitrectomy. Arch Ophthalmol (2000) 0.86

Cellular photoablation to control postoperative fibrosis in filtration surgery: in vitro studies. Exp Eye Res (2000) 0.85

Direct measurement of VEGF-induced nitric oxide production by choroidal endothelial cells. Microvasc Res (2001) 0.85

Loss of inwardly rectifying potassium currents by human retinal glial cells in diseases of the eye. Glia (1997) 0.85

Laceration of the eye with a fishing hook. Br J Ophthalmol (1999) 0.85

Retinal pigment epithelium melanin granules are phagocytozed by Müller glial cells in experimental retinal detachment. J Neurocytol (2001) 0.85

Detection of mRNA for proteins involved in retinol metabolism in iris pigment epithelium. Graefes Arch Clin Exp Ophthalmol (1999) 0.85

Pathogenesis of retinal detachment associated with morning glory disc. Int Ophthalmol (1995) 0.84

The intraocular foreign body. Principles and problems in the management of complicated cases by pars plana vitrectomy. Int Ophthalmol (1983) 0.84

Cellular photoablation to control postoperative fibrosis in a rabbit model of filtration surgery. Br J Ophthalmol (1999) 0.84

Human Müller glial cells: altered potassium channel activity in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci (1999) 0.84

Subretinal injection of rod outer segments leads to an increase in the number of early-stage melanosomes in retinal pigment epithelial cells. Ophthalmic Res (2000) 0.84

[Diabolic injury with the localization of foreign bodies in the apex of the intraorbital region ]. Klin Monbl Augenheilkd (2005) 0.84

[Intraocular gases in vitreous and retinal surgery. II: Clinical aspects]. Ophthalmologe (1999) 0.83

Iris pigment epithelial cells of long evans rats demonstrate phagocytic activity. Exp Eye Res (1997) 0.83

Phagocytosis of rod outer segments by human iris pigment epithelial cells in vitro. Graefes Arch Clin Exp Ophthalmol (1998) 0.83

The significance of fibronectin in vitreoretinal pathology. A critical evaluation. Graefes Arch Clin Exp Ophthalmol (1988) 0.83

Vitreous changes and retinal detachment in highly myopic eyes. Eur J Ophthalmol (1996) 0.83

The topoisomerase I inhibitors, camptothecin and beta-lapachone, induce apoptosis of human retinal pigment epithelial cells. Exp Eye Res (1998) 0.83

Comparative study of ROS degradation by IPE and RPE cells in vitro. Graefes Arch Clin Exp Ophthalmol (1999) 0.83

Vitrectomy for macular detachment associated with optic nerve pits. Int Ophthalmol (1997) 0.83

Unilateral pigmentary degeneration of the retina associated with heterochromia iridis. Graefes Arch Clin Exp Ophthalmol (1998) 0.83

Upregulation of the RAS-GTPase activating protein (GAP)-binding protein (G3BP) in proliferating RPE cells. J Cell Biochem (1999) 0.83

[Therapy approaches for geographic atrophy]. Ophthalmologe (2010) 0.83

Progressive subretinal fibrosis in a child following hemolytic uremic syndrome. Retina (1999) 0.83

Capillaries are present in Bruch's membrane at the ora serrata in the human eye. Invest Ophthalmol Vis Sci (1998) 0.82